NCT07064629

Brief Summary

This study aims to evaluate the effectiveness of a VR-based relaxation breathing training with biofeedback compared to a non-biofeedback version in patients with anxiety disorders. The randomized controlled trial will include at least 30 participants (15 per group) diagnosed with an anxiety disorder (DSM-5 or ICD-10 criteria). The intervention will use BreezeTerraVR, a custom-built virtual reality (VR) application developed by VR research center team members at NIMH. This app provides training in deep relaxation breathing technique with or without biofeedback (BF - visual elements reflecting real-time breathing patterns measured via breathing belt) in a virtual nature environment. This study compares two subgroups of anxiety patients, both completing four 20-minute intervention sessions, two sessions with BF and two without BF (in randomized order). This study will assess the feasibility of the VR intervention, estimate effect sizes, and provide preliminary insights into its impact on relaxation training in individuals with anxiety disorders. This study is funded by the European Union's co-financed project "Research of Excellence on Digital Technologies and Wellbeing CZ.02.01.01/00/22\_008/0004583."

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 21, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 13, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 15, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

July 18, 2025

Status Verified

July 1, 2025

Enrollment Period

11 months

First QC Date

June 13, 2025

Last Update Submit

July 15, 2025

Conditions

Keywords

Virtual realityrelaxationbreathing techniquesanxiety disordersbiofeedback

Outcome Measures

Primary Outcomes (3)

  • Respiratory rate

    Data from the breathing pattern (respiration effort and respiration rate) measured at the baseline before the beginning of the relaxation, during the relaxation, and a period after the relaxation. The measure is repeated in each session 1-4.

    - baseline/pre-intervention (for 3 minutes) - during the intervention (for 5 minutes) - immediately after the intervention (for 3 minutes)

  • Acute symptoms of anxiety

    Using the short version of the State-Trait Anxiety Inventory (STAI-6) questionnaire, measures of acute anxiety symptoms before and after each relaxation session (sessions 1-4). Higher scores indicate higher anxiety. The lowest possible score is 6 (minimum anxiety), and the highest is 24 (maximum anxiety).

    - baseline/pre-intervention (before each session) - and immediately after the intervention (after each session)

  • State of relaxation

    With the Relaxation State Questionnaire (RSQ), measured before and after each relaxation session (sessions 1-4). Higher scores imply higher subjective perception of being relaxed. The lowest possible score is 10 (the least relaxed), and the highest is 50 (maximum relaxation).

    - Baseline/pre-intervention (each session) - and immediately after the intervention (each session).

Secondary Outcomes (2)

  • Simulator sickness

    Immediately after finishing the final intervention session (Session 4).

  • Sense of presence

    Immediately after finishing the final intervention session (Session 4).

Study Arms (2)

Virtual reality relaxation breathing with/without biofeedback

EXPERIMENTAL

Intervention group 1: use of VR application for relaxation breathing in the first two sessions with biofeedback, followed by two sessions without biofeedback.

Behavioral: Relaxation in virtual reality with biofeedback.Behavioral: Relaxation in virtual reality without biofeedback

Virtual reality relaxation breathing without/with biofeedback

ACTIVE COMPARATOR

Intervention group 2: use of VR application for relaxation breathing in the first two sessions without biofeedback, followed by two sessions with biofeedback.

Behavioral: Relaxation in virtual reality with biofeedback.Behavioral: Relaxation in virtual reality without biofeedback

Interventions

In this intervention, biofeedback is provided based on the respiratory rate measured by a Vernier Go respiration belt. This belt sends signals (respiratory effort) to the application that calculates the level of synchronisation and gives the visual biofeedback in two forms: 1) a deer simultanously breathing with the participant (realtime biofeedback, present in the initial phase only), 2) a growing tree - if breathing is regulated following a given rhytm, a growing tree is giving the targeted biofeedback.

Also known as: withBF
Virtual reality relaxation breathing with/without biofeedbackVirtual reality relaxation breathing without/with biofeedback

In this control intervention, participants' respiratory rate is still being measured by the respiratory belt VernierGo; however, they are not receiving any visual biofeedback inside the virtual relaxation application (no deer is present, the tree is constantly growing regardless of the breathing pattern of the participant).

Also known as: withoutBF
Virtual reality relaxation breathing with/without biofeedbackVirtual reality relaxation breathing without/with biofeedback

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with Anxiety disorders

You may not qualify if:

  • severe neurological disease (e.g. epilepsia)
  • psychiatric disorders other then Anxiety disorder
  • serious somatic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Mental Health

Klecany, Czech Republic, 250 67, Czechia

Location

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Biofeedback, Psychology

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Study Officials

  • Iveta Fajnerova, PhD.

    National Institute of Mental Health (NIMH)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Supervisor

Study Record Dates

First Submitted

June 13, 2025

First Posted

July 15, 2025

Study Start

January 21, 2025

Primary Completion

December 30, 2025

Study Completion

December 30, 2025

Last Updated

July 18, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

IPD (primary outcome measures) that underlie results in a publication.

Shared Documents
STUDY PROTOCOL
Time Frame
IPD will be shared after the study publication, for at least 5 years.
Access Criteria
The anonymized preprocessed behavioral data will be shared using an open access repository. Additional raw data access requests will be reviewed using an online form. Requestors will be required to sign a data access agreement.

Locations